LU51306A1 - - Google Patents

Info

Publication number
LU51306A1
LU51306A1 LU51306A LU51306A LU51306A1 LU 51306 A1 LU51306 A1 LU 51306A1 LU 51306 A LU51306 A LU 51306A LU 51306 A LU51306 A LU 51306A LU 51306 A1 LU51306 A1 LU 51306A1
Authority
LU
Luxembourg
Application number
LU51306A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of LU51306A1 publication Critical patent/LU51306A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D489/00Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/09Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems
    • C07D489/10Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems with a bridge between positions 6 and 14
    • C07D489/12Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems with a bridge between positions 6 and 14 the bridge containing only two carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
LU51306A 1965-06-15 1966-06-13 LU51306A1 (en:Method)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB25289/65A GB1136214A (en) 1965-06-15 1965-06-15 Thebaine and oripavine derivatives

Publications (1)

Publication Number Publication Date
LU51306A1 true LU51306A1 (en:Method) 1966-08-16

Family

ID=10225305

Family Applications (1)

Application Number Title Priority Date Filing Date
LU51306A LU51306A1 (en:Method) 1965-06-15 1966-06-13

Country Status (14)

Country Link
AT (1) AT272530B (en:Method)
BE (1) BE682551A (en:Method)
BR (1) BR6680359D0 (en:Method)
CH (1) CH558362A (en:Method)
DE (1) DE1620206A1 (en:Method)
DK (1) DK115926B (en:Method)
ES (1) ES327925A1 (en:Method)
FI (1) FI49724C (en:Method)
FR (1) FR6395M (en:Method)
GB (1) GB1136214A (en:Method)
LU (1) LU51306A1 (en:Method)
NL (1) NL6608255A (en:Method)
NO (1) NO119590B (en:Method)
SE (1) SE325276B (en:Method)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2554816B1 (fr) * 1983-11-16 1986-09-26 Sanofi Sa Nouveau derive de la nororipavine presentant a la fois une activite agoniste et antagoniste des recepteurs morphiniques
KR100204659B1 (ko) * 1996-05-28 1999-06-15 강재헌 신규한 부프레노핀계 진통제용 화합물
RU2138502C1 (ru) * 1999-03-29 1999-09-27 Закрытое акционерное общество "РМА-Фарм" Способ получения 17-циклопропилметил-6,14-эндо-этано-7-(2-гидрокси-3,3-диметилбут-2-ил)тетр агидро-17-норорипавина
AUPQ968300A0 (en) 2000-08-25 2000-09-21 Glaxo Wellcome Australia Ltd Chemical methods
GB2388369B (en) 2002-05-10 2004-05-05 Reckitt Benckiser Healthcare Demethylation of thebaine derivative
GB0421687D0 (en) 2004-09-30 2004-11-03 Johnson Matthey Plc Preparation of opiate analgesics
WO2006091885A2 (en) 2005-02-24 2006-08-31 Dr Pharma Nova, Llc A registry method and control system for dea schedule ii-v medicines
DE102006054731B4 (de) 2006-11-21 2013-02-28 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System zur Verabreichung des Wirkstoffs Buprenorphin und Verwendung desselben in der Schmerztherapie
US8530494B2 (en) * 2008-07-30 2013-09-10 Purdue Pharma Lp Buprenophine analogs
US8293906B2 (en) 2008-09-30 2012-10-23 Mallinckrodt Llc Processes for the alkylation of norbuprenorphine with reduced impurity formation
NZ595591A (en) 2009-04-24 2013-11-29 Univ Brock Processes for the preparation of morphinane and morphinone compounds
GB201111775D0 (en) 2011-07-08 2011-08-24 Univ Bath Compounds and uses thereof
EA201491164A1 (ru) 2011-12-12 2014-10-30 ЭлТиЭс ЛОМАНН ТЕРАПИ-ЗЮСТЕМ АГ Трансдермальная система доставки
CN104661648B (zh) 2012-07-26 2019-04-05 卡姆拉斯公司 阿片样物质制剂
PE20150672A1 (es) 2012-07-26 2015-05-21 Camurus Ab Formulaciones de opioides
US9175000B2 (en) * 2012-12-07 2015-11-03 Purdue Pharma L.P. Buprenorphine analogs
WO2014195352A1 (en) 2013-06-04 2014-12-11 Lts Lohmann Therapie-Systeme Ag Transdermal delivery system
WO2023111125A1 (en) 2021-12-16 2023-06-22 Arevipharma Gmbh Method of making buprenorphine and precursor compounds thereof

Also Published As

Publication number Publication date
FR6395M (en:Method) 1968-10-21
FI49724B (en:Method) 1975-06-02
BR6680359D0 (pt) 1973-12-26
NO119590B (en:Method) 1970-06-08
AT272530B (de) 1969-07-10
NL6608255A (en:Method) 1966-12-16
DK115926B (da) 1969-11-24
SE325276B (en:Method) 1970-06-29
ES327925A1 (es) 1967-04-01
BE682551A (en:Method) 1966-11-14
GB1136214A (en) 1968-12-11
DE1620206A1 (de) 1970-03-19
FI49724C (fi) 1975-09-10
CH558362A (de) 1975-01-31

Similar Documents

Publication Publication Date Title
FI49724B (en:Method)
JPS5248932B1 (en:Method)
JPS4317059Y1 (en:Method)
FR1592057A (en:Method)
JPS4519879B1 (en:Method)
JPS4218454Y1 (en:Method)
JPS4413248Y1 (en:Method)
JPS4420074Y1 (en:Method)
JPS451234Y1 (en:Method)
BE675512A (en:Method)
BE674518A (en:Method)
NL6610140A (en:Method)
LU52097A1 (en:Method)
LU48696A1 (en:Method)
BE662897A (en:Method)
BE668594A (en:Method)
SE314442B (en:Method)
BE669258A (en:Method)
SE322147B (en:Method)
SE339187B (en:Method)
BE658570A (en:Method)
BE675235A (en:Method)
BE706702A (en:Method)
BE686926A (en:Method)
BE675606A (en:Method)